Share
array:23 [ "pii" => "S2173572722003095" "issn" => "21735727" "doi" => "10.1016/j.medine.2022.06.023" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "1805" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "copyrightAnyo" => "2022" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Intensiva. 2023;47:373-82" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "itemSiguiente" => array:18 [ "pii" => "S2173572722002077" "issn" => "21735727" "doi" => "10.1016/j.medine.2022.06.020" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "1810" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Med Intensiva. 2023;47:383-90" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "PEEP titration by EIT strategies for patients with ARDS: A systematic review and meta-analysis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "383" "paginaFinal" => "390" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Evaluación sistemática y metaanálisis de la estrategia eit para la titulación Peep en pacientes con sdra" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2052 "Ancho" => 2520 "Tamanyo" => 251720 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The subgroup analysis of PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span>-ratio.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mengnan Yu, Yanjun Deng, Jun Cha, Lingyan Jiang, Mingdeng Wang, Shigang Qiao, Chen Wang" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Mengnan" "apellidos" => "Yu" ] 1 => array:2 [ "nombre" => "Yanjun" "apellidos" => "Deng" ] 2 => array:2 [ "nombre" => "Jun" "apellidos" => "Cha" ] 3 => array:2 [ "nombre" => "Lingyan" "apellidos" => "Jiang" ] 4 => array:2 [ "nombre" => "Mingdeng" "apellidos" => "Wang" ] 5 => array:2 [ "nombre" => "Shigang" "apellidos" => "Qiao" ] 6 => array:2 [ "nombre" => "Chen" "apellidos" => "Wang" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572722002077?idApp=WMIE" "url" => "/21735727/0000004700000007/v1_202306271042/S2173572722002077/v1_202306271042/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2173572723000309" "issn" => "21735727" "doi" => "10.1016/j.medine.2023.03.010" "estado" => "S300" "fechaPublicacion" => "2023-07-01" "aid" => "1861" "copyright" => "Elsevier España, S.L.U. and SEMICYUC" "documento" => "article" "crossmark" => 1 "subdocumento" => "sco" "cita" => "Med Intensiva. 2023;47:371-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Ultrasound-guided arterial cannulation: Is the game over for the palpation technique?" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "371" "paginaFinal" => "372" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Canulación arterial ecodirigida: ¿se terminó el juego para la técnica palpatoria?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Pablo Blanco" "autores" => array:1 [ 0 => array:2 [ "nombre" => "Pablo" "apellidos" => "Blanco" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173572723000309?idApp=WMIE" "url" => "/21735727/0000004700000007/v1_202306271042/S2173572723000309/v1_202306271042/en/main.assets" ] "en" => array:20 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Prognostic value of the novel P/FPE index to classify ARDS severity: A cohort study" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "373" "paginaFinal" => "382" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "F.D. Martos-Benítez, R. Estévez-Muguercia, V. Orama-Requejo, T. del Toro-Simoni" "autores" => array:4 [ 0 => array:4 [ "nombre" => "F.D." "apellidos" => "Martos-Benítez" "email" => array:1 [ 0 => "fdmartos@infomed.sld.cu" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "R." "apellidos" => "Estévez-Muguercia" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "V." "apellidos" => "Orama-Requejo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "T." "apellidos" => "del Toro-Simoni" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Intensive Care Unit – 8, Hermanos Ameijeiras Hospital, Havana 10400, Cuba" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Intermediate Care Unit, Hospital of Palamos, Palamos 17230, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Intensive Care Unit, Manuel Ascunce Domenech Hospital, Camagüey 70600, Cuba" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Valor pronóstico del nuevo índice P/FPE para clasificar la severidad del SDRA: Estudio de cohorte" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2113 "Ancho" => 2508 "Tamanyo" => 152898 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Flow diagram of participants (dates of inclusion: between January 2018 and December 2020). ARDS<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>acute respiratory distress syndrome; ICU<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>intensive care unit; IMV<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>invasive mechanical ventilation.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome characterized by an acute inflammation, increased permeability, and edema of the lung tissue, with a typical histological hallmark of diffuse alveolar damage, leading to alveolar collapse and a severe impairment in oxygen diffusion.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">1</span></a> ARDS accounts for 10% of intensive care unit (ICU) admissions and 23% of patients receiving mechanical ventilation, with a mortality rate that ranges from 35% in mild cases to 46% in severe cases.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> According to the Berlin definition, severity of ARDS is classified into 3 categories (mild, moderate, and severe) based on the arterial partial pressure of oxygen to fraction of inspired oxygen (PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span>) ratio, with a minimum positive end-expiratory pressure (PEEP) level of 5<span class="elsevierStyleHsp" style=""></span>cm H<span class="elsevierStyleInf">2</span>O.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">3</span></a> These criteria have been useful for designing clinical trials and observational studies, as well as for improving clinical decision-makings and therapeutic interventions.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">However, the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio has some limitations for assessing ARDS severity. First, PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio is affected by ventilatory setting such as PEEP and inspiratory/expiratory time ratio. Villar et al. improved ARDS risk stratification using standard ventilatory settings (PEEP<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>10<span class="elsevierStyleHsp" style=""></span>cmH<span class="elsevierStyleInf">2</span>O and FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>0.5).<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">5,6</span></a> Second, PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio may change over time. A number of authors found a better mortality prediction by patients’ reclassification ≥24<span class="elsevierStyleHsp" style=""></span>h after ARDS onset.<a class="elsevierStyleCrossRefs" href="#bib0205"><span class="elsevierStyleSup">5–7</span></a> And third, PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio is not always linked to mortality in patients with ARDS.<a class="elsevierStyleCrossRefs" href="#bib0220"><span class="elsevierStyleSup">8,9</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Recently, Sayed and coworkers proposed a novel criterion to address Berlin definition gap by including PEEP in the new index named P/FP<span class="elsevierStyleInf">E</span>, defined as PaO<span class="elsevierStyleInf">2</span>/(FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>PEEP). The increase the PEEP level with the same FiO<span class="elsevierStyleInf">2</span> yields different degree of blood oxygenation. By using machine learning approaches, the authors demonstrated that the P/FP<span class="elsevierStyleInf">E</span> index after onset and at third day is markedly better than the current PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio to assess ARDS severity.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">10</span></a> The present study was aimed to evaluate the impact of the P/FP<span class="elsevierStyleInf">E</span> index on mortality of patients with ARDS.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Patients and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Design and setting</span><p id="par0020" class="elsevierStylePara elsevierViewall">The current study is presented as stated by The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (<a class="elsevierStyleCrossRef" href="#sec0095">Supplementary material 1</a>).<a class="elsevierStyleCrossRef" href="#bib0235"><span class="elsevierStyleSup">11</span></a> This is a retrospective cohort study of patients collected between January 2018 and December 2020 in the medical and surgical ICU-8 of the Hermanos Ameijeiras Hospital. This is a 640-bed, university-affiliated, tertiary referral hospital in Havana, Cuba. The ICU-8 has 12 beds and provides care for approximately 300–350 critically ill patients per year. Information regarding origin, demography, epidemiology, chronic comorbidities, clinical status, laboratory tests, image results, and outcomes of all patients were recorded in the ICU-8 database by the attending physician day by day from patients’ admission until discharge or death. Quality of data was daily verified by a supervisor physician. A complete list of data used for this study is provided in <a class="elsevierStyleCrossRef" href="#sec0095">Supplementary material 2</a>.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The current study was conducted in accordance with the 1964 Helsinki Declaration, and was approved by the Scientific Council and the Ethics Committee for Scientific Research of the Hermanos Ameijeiras Hospital (Approval number 01-10-06-2021). Written informed consent was waived in view of retrospective nature of the study.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0120">Subjects</span><p id="par0030" class="elsevierStylePara elsevierViewall">All consecutive subjects with ARDS admitted to ICU were included. The following subjects were excluded: 1. Subjects without invasive mechanical ventilation (IMV), because failure in noninvasive respiratory support therapies may have a negative impact on outcomes<a class="elsevierStyleCrossRefs" href="#bib0240"><span class="elsevierStyleSup">12,13</span></a>; 2. Subjects with duration of IMV ≤48<span class="elsevierStyleHsp" style=""></span>h to improve ARDS classification,<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">7,9,10,14</span></a> and avoid confounders related to systemic pathophysiological disturbances of the acutely ill patients; and 3. Subjects on IMV before ARDS onset, since several clinical, therapeutic, and ventilatory setting confounders may contribute for developing ARDS in subjects previously intubated for other reasons and may have effects on outcomes.<a class="elsevierStyleCrossRefs" href="#bib0255"><span class="elsevierStyleSup">15,16</span></a> Finally, 217 subjects were analyzed (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0125">Data collection</span><p id="par0035" class="elsevierStylePara elsevierViewall">The following data were recorded on ICU admission: age, sex, body mass index, predictive body weight (PBW), history of chronic diseases, length of hospitalization before ICU admission, reason for ICU admission, type of patient, Simplified Acute Physiology Score (SAPS) 3, Sequential Organ Failure Assessment (SOFA) score, and use and dose of vasoactive drugs. Within 2<span class="elsevierStyleHsp" style=""></span>h after starting IMV the following variables were collected: ventilatory setting (ventilatory mode, peak inspiratory pressure, plateau pressure, mean pressure, PEEP, driving pressure, tidal volume, tidal volume/PBW, respiratory rate, minute ventilation, standardized minute ventilation, static compliance, and FiO<span class="elsevierStyleInf">2</span>), recruitment maneuvers, prone positioning, infusion of neuromuscular blocking agents, pH and blood gases parameters (hemoglobin oxygen saturation, arterial partial pressure of oxygen, arterial partial pressure of carbon dioxide). Risk factors for ARDS were collected on ARDS diagnosis. ICU-acquired ARDS was defined as ARDS onset >48<span class="elsevierStyleHsp" style=""></span>h after ICU admission.<a class="elsevierStyleCrossRef" href="#bib0265"><span class="elsevierStyleSup">17</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0130">ARDS severity evaluation</span><p id="par0040" class="elsevierStylePara elsevierViewall">Severity of ARDS was assessed on day 1 (within 2<span class="elsevierStyleHsp" style=""></span>h after starting IMV) and day 3 (within 48–72<span class="elsevierStyleHsp" style=""></span>h after starting IMV) with the patient in supine position. All subjects were stratified into mild (200<span class="elsevierStyleHsp" style=""></span>mm Hg<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>300<span class="elsevierStyleHsp" style=""></span>mm Hg), moderate (100<span class="elsevierStyleHsp" style=""></span>mm Hg<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>200<span class="elsevierStyleHsp" style=""></span>mm Hg) or severe ARDS (PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio ≤100<span class="elsevierStyleHsp" style=""></span>mm Hg) in line with the Berlin definition.<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">3</span></a> According to P/FP<span class="elsevierStyleInf">E</span> index, patients were classified as mild (40<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>P/FP<span class="elsevierStyleInf">E</span> index<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>60), moderate (20<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>P/FP<span class="elsevierStyleInf">E</span> index<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>40) or severe ARDS (P/FP<span class="elsevierStyleInf">E</span> index<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>20).<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">10</span></a> All cases had PEEP<span class="elsevierStyleHsp" style=""></span>≥<span class="elsevierStyleHsp" style=""></span>5<span class="elsevierStyleHsp" style=""></span>cm H<span class="elsevierStyleInf">2</span>O; minimal PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index values were used because minimal values during the day might better predict mortality. Diagnosis and severity of ARDS along with decision-making for therapeutic interventions were collectively taken by the physician team of the ICU (all of them blinded to the study objective).</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0135">Ventilatory management</span><p id="par0045" class="elsevierStylePara elsevierViewall">Ventilatory adjustments of patients were left to the attending physician, but by using a protective approach. For patients with PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio<span class="elsevierStyleHsp" style=""></span>≤<span class="elsevierStyleHsp" style=""></span>150<span class="elsevierStyleHsp" style=""></span>mm Hg, prone positioning, lung recruitment maneuvers, higher PEEP, and neuromuscular blocking agents were considered.<a class="elsevierStyleCrossRef" href="#bib0270"><span class="elsevierStyleSup">18</span></a> Sedative and analgesic drugs were used as needed. Ventilatory settings and arterial blood gases on day 1 and day 3 are depicted in <a class="elsevierStyleCrossRef" href="#sec0095">Supplementary Table 1 (Supplementary material 3)</a>.</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0140">Outcomes</span><p id="par0050" class="elsevierStylePara elsevierViewall">Primary outcome of interest was the hospital mortality. Secondary outcomes were ICU mortality, duration of IMV, length of ICU stay, and length of hospitalization.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0145">Statistical analysis</span><p id="par0055" class="elsevierStylePara elsevierViewall">Study objective was unknown for attending physicians, nurses and patients, which allowed to minimize the following sources of biases: 1. Over or underreport of ARDS; 2. Selective ICU admission of patients with ARDS; 3. Selective detection of ICU-acquired ARDS; and 4. Selective use of any therapeutic intervention with impact on clinical outcomes.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Assuming hospital mortality rates of 20% in mild ARDS patients and 40% in severe ARDS patients on 3 day after starting IMV, as previously reported by Sayed and coworkers using large datasets,<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">10</span></a> with a statistical power of 80% and two-side confidence level of 95%, we calculated a sample size of 166 patients. Finally, we enrolled 217 patients.</p><p id="par0065" class="elsevierStylePara elsevierViewall">Multiple imputation method was used for treating missing values. Categorical variables are shown as absolute numbers with percentage, whereas numerical variables are represented as median with 25–75 interquartile rank (IQR). Differences between groups were assessed using chi-square test for categorical variables and Mann–Whitney <span class="elsevierStyleItalic">U</span> test for continuous variables.</p><p id="par0070" class="elsevierStylePara elsevierViewall">Multivariate logistic regression analysis was used to explore the impact of ventilatory settings and respiratory indexes on primary outcome. Model assumptions were verified. To avoid collinearity, after checking the correlation matrix, only weakly correlated and clinically significant covariates were included. SOFA score was included as a covariate in order to interpret results in a valid clinical scenario. Two models were explored, the first used the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio as a covariate, and the second used the P/FP<span class="elsevierStyleInf">E</span> index.</p><p id="par0075" class="elsevierStylePara elsevierViewall">The area under receiver operating characteristic curve (AROC) and the correlation between the predicted and actual value (CORR) were used to assess the performance of the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index in predicting hospital mortality. For assessment the incremental value of the P/FP<span class="elsevierStyleInf">E</span> index compared to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio, the quantitative net reclassification improvement (qNRI, for quantifying the amount of correct change in predicting hospital mortality by using the P/FP<span class="elsevierStyleInf">E</span> index relative to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio) and the integrated discrimination improvement (IDI, for quantifying the increase in separation of events and nonevents of death by using the P/FP<span class="elsevierStyleInf">E</span> index relative to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio) with its 95% confidence interval (CI) were estimated.</p><p id="par0080" class="elsevierStylePara elsevierViewall">Statistical tests with a two-tailed <span class="elsevierStyleItalic">p</span>-value <0.05 were considered as significant. Data were analyzed using IBM®SPSS® Statistics 23.0 (IBM, Chicago, IL, USA).</p></span></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0150">Results</span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0155">Characteristics of patients</span><p id="par0085" class="elsevierStylePara elsevierViewall">In the 217 studied patients, the most common chronic comorbidities were hypertension, cancer, and immunoincompetence. The main reasons for ICU admission were acute respiratory failure, shock, and disturbed consciousness. Nonsurgical and surgical patients accounted for 61.8% and 38.2% of participants, respectively. The median SOFA score was 8.0 points, and the median SAPS 3 score was 55.0 points. During the ICU stay, vasoactive drugs were used in 36.4% of patients. ICU and hospital mortality rates were 41.0% and 59.9%, respectively. History of cardiovascular diseases, type of patient, and SOFA score were associated with hospital mortality in univariate analysis (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Pneumonia, noncardiogenic shock, and extrapulmonary sepsis were the most common risk factors for ARDS. ICU-acquired ARDS accounted for 22.9% of subjects and was related to increased mortality (13.8% vs. 28.5%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.011). General characteristics of patients are depicted in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>. Relationship of ventilatory settings and arterial blood gases with hospital mortality is illustrated in <a class="elsevierStyleCrossRef" href="#sec0095">Supplementary Tables 2 and 3 (see Supplementary material 3)</a>.</p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0160">ARDS severity classification</span><p id="par0095" class="elsevierStylePara elsevierViewall">The median PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index on first day after starting IMV was 187.0<span class="elsevierStyleHsp" style=""></span>mm Hg (IQR 117.3–221.8<span class="elsevierStyleHsp" style=""></span>mm Hg) and 21.6 (IQR 10.2–33.2), respectively. On third day, the median value of PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio was 222.5<span class="elsevierStyleHsp" style=""></span>mm Hg (IQR 176.7–297.8<span class="elsevierStyleHsp" style=""></span>mm Hg) and the median value of P/FP<span class="elsevierStyleInf">E</span> index was 23.3 (IQR 15.8–37.5).</p><p id="par0100" class="elsevierStylePara elsevierViewall">According to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio on day 1, 30.9%, 46.5%, and 22.6% of patients had a mild, moderate, and severe ARDS, respectively; on day 3, 23.0% of patients were free of ARDS while patients with mild, moderate, and severe ARDS accounted for 42.4%, 31.3%, and 3.2%, respectively. Using the P/FP<span class="elsevierStyleInf">E</span> index on day 1, patients with mild, moderate, and severe ARDS accounted for 18.0%, 39.6%, and 42.4%, respectively; on day 3, 6.5% of patients were free of ARDS, whereas 14.3%, 40.6%, and 38.7% had a mild, moderate, and severe ARDS, respectively.</p><p id="par0105" class="elsevierStylePara elsevierViewall">A number of patients were reclassified into a different category of ARDS severity by using the P/FP<span class="elsevierStyleInf">E</span> index (31.8% on day 1 and 77.0% on day 3) (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). Of note, 72% of patients without ARDS by the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio on day 3 remained with ARDS by using the P/FP<span class="elsevierStyleInf">E</span> index (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>). Severity of ARDS was linked to a higher PEEP level; however, the level of PEEP was lower by the P/FP<span class="elsevierStyleInf">E</span> index-based ARDS severity than using the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio-based ARDS severity (<a class="elsevierStyleCrossRef" href="#fig0015">Fig. 3</a>).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0165">ARDS severity and outcomes</span><p id="par0110" class="elsevierStylePara elsevierViewall">PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index was related to mortality both on day 1 and day 3 (<a class="elsevierStyleCrossRef" href="#sec0095">Supplementary figure 1, Supplementary material 3</a>). However, on multivariate analyses only the P/FP<span class="elsevierStyleInf">E</span> index was consistently associated with hospital mortality (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Driving pressure, tidal volume/PBW and SOFA score were also independent risk factors related to increased mortality (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0115" class="elsevierStylePara elsevierViewall">The capability of the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index for predicting hospital mortality improved from day 1 to day 3. Nonetheless, the performance of the P/FP<span class="elsevierStyleInf">E</span> index was superior to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio in term of AROC (<span class="elsevierStyleItalic">day 1</span> 0.72 vs. 0.62; <span class="elsevierStyleItalic">day 3</span> 0.87 vs. 0.68) and CORR (<span class="elsevierStyleItalic">day 1</span> 0.370 vs. 0.213; <span class="elsevierStyleItalic">day 3</span> 0.634 vs. 0.301) (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> and <a class="elsevierStyleCrossRef" href="#sec0095">Supplementary figure 2, Supplementary material 3</a>). P/FP<span class="elsevierStyleInf">E</span> index improved the prediction of risk of death compared to PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio as showed by the qNRI (<span class="elsevierStyleItalic">day 1</span> 72.0%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001; <span class="elsevierStyleItalic">day 3</span> 132.4%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001) and IDI (<span class="elsevierStyleItalic">day 1</span> 0.09, 95% CI 0.06–0.12, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001; <span class="elsevierStyleItalic">day 3</span> 0.31, 95% CI 0.26–0.35, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001) (<a class="elsevierStyleCrossRef" href="#sec0095">Supplementary figures 3 and 4, Supplementary material 3</a>).</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia></span></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0170">Discussion</span><p id="par0120" class="elsevierStylePara elsevierViewall">The present study found that 31.8% of patients with ARDS on day 1 and 77.0% on day 3 were reclassified into a different category of ARDS severity using the P/FP<span class="elsevierStyleInf">E</span> index. The performance for predicting hospital mortality increased with the P/FP<span class="elsevierStyleInf">E</span> index, compared to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio. The P/FP<span class="elsevierStyleInf">E</span> index and ventilatory settings, such as tidal volume and driving pressure, were independently related to increased mortality in multivariate analysis. ARDS severity stratification improved on third day after ARDS diagnosis. Mean PEEP level was lower when ARDS severity was categorized according to the P/FP<span class="elsevierStyleInf">E</span> index rather than the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio.</p><p id="par0125" class="elsevierStylePara elsevierViewall">In order to overcome the gap of the Berlin criteria, Sayed et al. recently proposed the PaO<span class="elsevierStyleInf">2</span> to (FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>PEEP) ratio, named P/FP<span class="elsevierStyleInf">E</span> index, as a novel criterion to reclassify ARDS patients in terms of severity.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">10</span></a> Improvement of ARDS severity classification is essential for current critical care medicine since misclassification may lead to errors in clinical judgment and decision-making. For instance, we found that a number of patients were reclassified in a higher category of ARDS severity using the P/FP<span class="elsevierStyleInf">E</span> index, whereas 72.0% of patients without ARDS on day 3 according to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio truly had ARDS by the P/FP<span class="elsevierStyleInf">E</span> index. Recently, Palanidurai et al. observed that more than half of the patients were reclassified into a different severity category of ARDS by the P/FP<span class="elsevierStyleInf">E</span> index, compared to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio. These similar results indicate that changes in severity classification with the P/FP<span class="elsevierStyleInf">E</span> index reflect the true severity of ARDS and the applied PEEP strategy.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">19</span></a></p><p id="par0130" class="elsevierStylePara elsevierViewall">Under-recognition of ARDS is a common and serious problem with important clinical consequences, particularly in terms of therapeutic options not considered.<a class="elsevierStyleCrossRef" href="#bib0280"><span class="elsevierStyleSup">20</span></a> The LUNG SAFE study demonstrated that the diagnosis of ARDS is delayed or missed in 40% of patients.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> P/FP<span class="elsevierStyleInf">E</span> index is able to identify patients with ARDS who would not be classified with ARDS according to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio, and is also a better predictor of mortality.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">19</span></a> Therefore, by using the P/FP<span class="elsevierStyleInf">E</span> index clinicians may implement strategies to improve mortality such as optimal PEEP, lower FiO<span class="elsevierStyleInf">2</span>, prone positioning and the use of neuromuscular blocking agents.</p><p id="par0135" class="elsevierStylePara elsevierViewall">PEEP is a confounder in clinical practice since optimal PEEP is difficult to obtain through several methods,<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">21</span></a> and clinicians commonly prescribes high PEEP in patients with adequate oxygenation goals.<a class="elsevierStyleCrossRefs" href="#bib0210"><span class="elsevierStyleSup">6,22</span></a> Clinical interpretation of the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio may be biased by nonpulmonary factors such as hemoglobin concentration and arterial-venous oxygen content difference.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">23</span></a> Consequently, oxygen toxicity with adverse impact on outcomes may be developed due to excess FiO<span class="elsevierStyleInf">2</span>.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">24</span></a> P/FP<span class="elsevierStyleInf">E</span> index is attractive because physicians can achieve the best combination of FiO<span class="elsevierStyleInf">2</span> and PEEP to reach adequate oxygenation. In our cohort, the frequency of prone positioning was similar to that reported in epidemiologic studies while infusion of neuromuscular blocking agents was lower.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> However, the use of these drugs is controversial because of its side effects and unclear benefits<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">25</span></a>; currently they are indicated only for the treatment of ventilatory asynchrony, supporting pronation, or assuring protective ventilation goals.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">21</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Our findings demonstrated the clinical validity of P/FP<span class="elsevierStyleInf">E</span> index. The better performance, compared to PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio, shows the usefulness of P/FP<span class="elsevierStyleInf">E</span> index in predicting mortality. Palanidurai et al. also found that P/FP<span class="elsevierStyleInf">E</span> index has a greater predictive validity for predicting hospital mortality in ARDS patients than the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">19</span></a> In fact, the AROC for P/FP<span class="elsevierStyleInf">E</span> index (0.71 vs. 0.72) and PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio (0.66 vs. 0.62) was similar to the present study, which supports external validity of our results.</p><p id="par0145" class="elsevierStylePara elsevierViewall">ARDS is one of the major reasons of ICU admission, and continues to have high mortality rates despite advances in supportive care.<a class="elsevierStyleCrossRefs" href="#bib0190"><span class="elsevierStyleSup">2,26</span></a> Ventilatory support is the keystone in the management of patients with ARDS, but ventilatory setting may have an impact on outcomes.<a class="elsevierStyleCrossRef" href="#bib0315"><span class="elsevierStyleSup">27</span></a> Since tidal volume and driving pressure, along with the P/FP<span class="elsevierStyleInf">E</span> index, were related to increased mortality in multivariate analysis, our findings suggest that the negative effect of ventilatory variables remains unchanged through the course of the disease, which is in line with recent evidences.<a class="elsevierStyleCrossRefs" href="#bib0320"><span class="elsevierStyleSup">28,29</span></a> Additionally, the relationship between the P/FP<span class="elsevierStyleInf">E</span> index with mortality explains ARDS severity, but also the potentially harmful effects of PEEP.</p><p id="par0150" class="elsevierStylePara elsevierViewall">The present study confirmed that ARDS severity stratification is improved on third day after ARDS diagnosis.<a class="elsevierStyleCrossRefs" href="#bib0215"><span class="elsevierStyleSup">7,10</span></a> Lai et al. demonstrated that the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio after a period of stabilization may be a more appropriate predictor of mortality than the initial PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio at the onset of ARDS.<a class="elsevierStyleCrossRef" href="#bib0330"><span class="elsevierStyleSup">30</span></a> Chiu et al. found that patients with resolved or improving ARDS severity on day 3 had lower mortality, whereas patients with the same or worsening ARDS severity on day 3 had higher mortality.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">7</span></a> Apparently, patients need to be exposed to a sufficient period of time for response to medical therapies and adjusted IMV settings before being classified.</p><p id="par0155" class="elsevierStylePara elsevierViewall">We found that a lower mean PEEP was used in all class of ARDS severity when patients were stratified by P/FP<span class="elsevierStyleInf">E</span> index, which might reduce the risk of excess PEEP. Palanidurai et al. observed that the predictive validity of P/FP<span class="elsevierStyleInf">E</span> index improved with progressively higher levels of PEEP, indicative of the negative effects of higher PEEP.<a class="elsevierStyleCrossRef" href="#bib0275"><span class="elsevierStyleSup">19</span></a> PEEP is not considered for ARDS severity evaluation by the Berlin definition. Adding PEEP to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio takes into consideration the respiratory system compliance and lung recruitment. Furthermore, by using PEEP as a quantitative variable, P/FP<span class="elsevierStyleInf">E</span> index conserves information and improves accuracy of estimations.<a class="elsevierStyleCrossRef" href="#bib0335"><span class="elsevierStyleSup">31</span></a> However, although PEEP increases functional residual capacity and improves blood oxygenation, tissue oxygen delivery decreases because of reduced cardiac output.<a class="elsevierStyleCrossRef" href="#bib0340"><span class="elsevierStyleSup">32</span></a> PEEP also increases the risk of volutrauma and ventilator-induced lung injury,<a class="elsevierStyleCrossRef" href="#bib0345"><span class="elsevierStyleSup">33</span></a> causing increased mortality when a high-PEEP strategy is used.<a class="elsevierStyleCrossRef" href="#bib0350"><span class="elsevierStyleSup">34</span></a></p><p id="par0160" class="elsevierStylePara elsevierViewall">This study has a number of strengths. First, the study was conducted in a center with high standard of health care and in an ICU with qualified intensivists 24<span class="elsevierStyleHsp" style=""></span>h a day, seven days a week. Second, potential sources of bias were reduced, which lend additional strength to our analysis. Third, this is a well-powered study with a representative sample size so estimation errors were minimized. Fourth, by multivariate analysis we were able to control for potential confounders including ventilatory setting, and severity of illness. Fifth, the LUNG SAFE study showed that most ARDS patients are not ventilated using a protective ventilation approach.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> We reached ventilatory goals on day 3, which indicates an improvement in quality of ventilatory management according to current recommendations.<a class="elsevierStyleCrossRefs" href="#bib0270"><span class="elsevierStyleSup">18,29</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">There are several limitations of our study. First, this is an observational study from a single center, thus results may not be representative of other institutions or regions. Second, a mixed cohort of surgical and nonsurgical patients with several clinical and pathophysiological disorders were analyzed, which could have effects on outcomes. Indeed, hospital mortality rate was higher than reported in recent epidemiologic studies.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> Since our hospital is a national referral center, case-mix of patients with more severe diseases were more likely included compared with community-based hospitals. Compared with patients enrolled in the LUNG SAFE study,<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">2</span></a> our analyzed patients had more chronic diseases including immunoincompetence, cardiovascular disease, and cancer, and had a higher rate of extrapulmonary sepsis and noncardiogenic shock, all which may explain the higher mortality rate observed in the study. Third, trauma patients were not included in the study so results cannot be applied to this type of patients. Fourth, several phenotypes and subphenotypes have been recognized in ARDS patients with impact on outcomes.<a class="elsevierStyleCrossRefs" href="#bib0355"><span class="elsevierStyleSup">35,36</span></a> In the present study, analyses were not stratified according to ARDS phenotypes; consequently, further studies are required to define the effects of the interaction or association of P/FP<span class="elsevierStyleInf">E</span> index-based ARDS severity and ARDS phenotypes, as well as its clinical implications, which opens a new agenda of work for future researches. Finally, we explored ARDS severity within the first 72<span class="elsevierStyleHsp" style=""></span>h after starting IMV, and the clinical course of patients beyond this period of time may affect outcomes.</p><p id="par0170" class="elsevierStylePara elsevierViewall">In conclusion, assessment of ARDS severity based on P/FP<span class="elsevierStyleInf">E</span> index is better than current PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> criteria for predicting mortality, especially on third day after starting IMV. P/FP<span class="elsevierStyleInf">E</span> index is easy to use at the bedside by involving information of the two therapeutic strategies used for managing hypoxemia such as FiO<span class="elsevierStyleInf">2</span> and PEEP. We recommend further clinical trials to clarify the advantages of ARDS severity classification based on P/FP<span class="elsevierStyleInf">E</span> index for clinical decision-making.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0175">Author's contributions</span><p id="par0175" class="elsevierStylePara elsevierViewall">FDMB contributed in the concepts, design, definition of intellectual content, literature search, clinical studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing, and manuscript review.</p><p id="par0180" class="elsevierStylePara elsevierViewall">REM and VOR contributed in the design, definition of intellectual content, clinical studies, data acquisition, manuscript editing, and manuscript review.</p><p id="par0185" class="elsevierStylePara elsevierViewall">TTS contributed in the literature search, manuscript preparation, manuscript editing, and manuscript review.</p></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0180">Funding</span><p id="par0190" class="elsevierStylePara elsevierViewall">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0185">Conflict of interest</span><p id="par0195" class="elsevierStylePara elsevierViewall">The authors declare that they have no competing interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:12 [ 0 => array:3 [ "identificador" => "xres1921890" "titulo" => "Abstract" "secciones" => array:8 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Design" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Setting" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Patients" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Interventions" ] 5 => array:2 [ "identificador" => "abst0030" "titulo" => "Variables" ] 6 => array:2 [ "identificador" => "abst0035" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1657766" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1921891" "titulo" => "Resumen" "secciones" => array:8 [ 0 => array:2 [ "identificador" => "abst0045" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0050" "titulo" => "Diseño" ] 2 => array:2 [ "identificador" => "abst0055" "titulo" => "Contexto" ] 3 => array:2 [ "identificador" => "abst0060" "titulo" => "Pacientes" ] 4 => array:2 [ "identificador" => "abst0065" "titulo" => "Intervenciones" ] 5 => array:2 [ "identificador" => "abst0070" "titulo" => "Variables" ] 6 => array:2 [ "identificador" => "abst0075" "titulo" => "Resultados" ] 7 => array:2 [ "identificador" => "abst0080" "titulo" => "Conclusiones" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1657767" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:3 [ "identificador" => "sec0010" "titulo" => "Patients and methods" "secciones" => array:7 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Design and setting" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Subjects" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Data collection" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "ARDS severity evaluation" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Ventilatory management" ] 5 => array:2 [ "identificador" => "sec0040" "titulo" => "Outcomes" ] 6 => array:2 [ "identificador" => "sec0045" "titulo" => "Statistical analysis" ] ] ] 6 => array:3 [ "identificador" => "sec0050" "titulo" => "Results" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0055" "titulo" => "Characteristics of patients" ] 1 => array:2 [ "identificador" => "sec0060" "titulo" => "ARDS severity classification" ] 2 => array:2 [ "identificador" => "sec0065" "titulo" => "ARDS severity and outcomes" ] ] ] 7 => array:2 [ "identificador" => "sec0070" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0075" "titulo" => "Author's contributions" ] 9 => array:2 [ "identificador" => "sec0080" "titulo" => "Funding" ] 10 => array:2 [ "identificador" => "sec0085" "titulo" => "Conflict of interest" ] 11 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2022-02-23" "fechaAceptado" => "2022-06-07" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1657766" "palabras" => array:6 [ 0 => "Acute respiratory distress syndrome/classification" 1 => "Acute respiratory distress syndrome/diagnosis" 2 => "Acute respiratory distress syndrome/mortality" 3 => "Mechanical ventilation" 4 => "Positive end-expiratory pressure" 5 => "Protective ventilation" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec1657767" "palabras" => array:6 [ 0 => "Síndrome de distrés respiratorio agudo/clasificación" 1 => "Síndrome de distrés respiratorio agudo/diagnóstico" 2 => "Síndrome de distrés respiratorio agudo/mortalidad" 3 => "Ventilación mecánica" 4 => "Presión positiva tele-espiratoria" 5 => "Ventilación protectiva" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objective</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">To evaluate the impact of the novel P/FP<span class="elsevierStyleInf">E</span> index to classify ARDS severity on mortality of patients with ARDS.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Design</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A retrospective cohort study.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Setting</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Twelve-bed medical and surgical intensive care unit from January 2018 to December 2020.</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Patients</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">A total of 217 ARDS patients managed with invasive mechanical ventilation >48<span class="elsevierStyleHsp" style=""></span>h.</p></span> <span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Interventions</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">None.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Variables</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">ARDS severity on day 1 and day 3 was measured based on PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index [PaO<span class="elsevierStyleInf">2</span>/(FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>PEEP)]. Primary outcome was the hospital mortality.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Hospital mortality rate was 59.9%. Relative to PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio, 31.8% of patients on day 1 and 77.0% on day 3 were reclassified into a different category of ARDS severity by P/FP<span class="elsevierStyleInf">E</span> index. The level of PEEP was lower by P/FP<span class="elsevierStyleInf">E</span> index-based ARDS severity classification than by using PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio. The performance for predicting mortality of P/FP<span class="elsevierStyleInf">E</span> index was superior to PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio in term of AROC (<span class="elsevierStyleItalic">day 1:</span> 0.72 vs. 0.62; <span class="elsevierStyleItalic">day 3:</span> 0.87 vs. 0.68) and CORR (<span class="elsevierStyleItalic">day 1:</span> 0.370 vs. 0.213; <span class="elsevierStyleItalic">day 3:</span> 0.634 vs. 0.301). P/FP<span class="elsevierStyleInf">E</span> index improved prediction of risk of death compared to PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio as showed by the qNRI (<span class="elsevierStyleItalic">day 1:</span> 72.0%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001; <span class="elsevierStyleItalic">day 3:</span> 132.4%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001) and IDI (<span class="elsevierStyleItalic">day 1:</span> 0.09, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001; <span class="elsevierStyleItalic">day 3:</span> 0.31, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.0001).</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Assessment of ARDS severity based on P/FP<span class="elsevierStyleInf">E</span> index seems better than PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio for predicting mortality. The value of P/FP<span class="elsevierStyleInf">E</span> index for clinical decision-making requires confirmation by randomized controlled trials.</p></span>" "secciones" => array:8 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objective" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Design" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Setting" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Patients" ] 4 => array:2 [ "identificador" => "abst0025" "titulo" => "Interventions" ] 5 => array:2 [ "identificador" => "abst0030" "titulo" => "Variables" ] 6 => array:2 [ "identificador" => "abst0035" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusions" ] ] ] "es" => array:3 [ "titulo" => "Resumen" "resumen" => "<span id="abst0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Objetivo</span><p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Evaluar el impacto del índice P/FP<span class="elsevierStyleInf">E</span> para clasificar la severidad del SDRA y su relación con la mortalidad.</p></span> <span id="abst0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Diseño</span><p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Estudio de cohorte retrospectivo.</p></span> <span id="abst0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Contexto</span><p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">Unidad de cuidados intensivos polivalentes de 12 camas desde enero de 2018 hasta diciembre de 2020.</p></span> <span id="abst0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Pacientes</span><p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Se estudió a 217 pacientes con SDRA con ventilación invasiva<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>48 horas.</p></span> <span id="abst0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Intervenciones</span><p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">Ninguna.</p></span> <span id="abst0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Variables</span><p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">La severidad del SDRA se evaluó el primer y el tercer día, según el índice PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> y el índice P/FP<span class="elsevierStyleInf">E</span> (PaO<span class="elsevierStyleInf">2</span>/[FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>PEEP]). El desenlace primario evaluado fue la mortalidad hospitalaria.</p></span> <span id="abst0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Resultados</span><p id="spar0075" class="elsevierStyleSimplePara elsevierViewall">La mortalidad hospitalaria fue 59,9%. Con relación al índice PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span>, el 31,8% de los pacientes el día 1 y el 77,0% el día 3 fue reclasificado en categorías diferentes de severidad del SDRA mediante el índice P/FP<span class="elsevierStyleInf">E</span>. El nivel de PEEP fue más bajo con el uso del índice P/FP<span class="elsevierStyleInf">E</span> que con el PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span>. La predicción de la mortalidad fue superior con el índice P/FP<span class="elsevierStyleInf">E</span> que con PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span>, en términos de AROC (día 1: 0,72 vs. 0,62; día 3: 0,87 vs. 0,68) y CORR (día 1: 0,370 vs. 0,213; día 3: 0,634 vs. 0,301). El índice P/FP<span class="elsevierStyleInf">E</span> mejoró la predicción del riesgo de muerte comparado con el PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span>, como demuestra el qNRI (día 1: 72,0%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001; día 3: 132,4%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001) y el IDI (día 1: 0,09, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001; día 3: 0,31, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0,0001).</p></span> <span id="abst0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Conclusiones</span><p id="spar0080" class="elsevierStyleSimplePara elsevierViewall">La evaluación de severidad del SDRA mediante el índice P/FP<span class="elsevierStyleInf">E</span> parece ser mejor que la del índice PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> para predecir la mortalidad. El valor del P/FP<span class="elsevierStyleInf">E</span> para la toma de decisiones clínicas requiere confirmación mediante ensayos clínicos.</p></span>" "secciones" => array:8 [ 0 => array:2 [ "identificador" => "abst0045" "titulo" => "Objetivo" ] 1 => array:2 [ "identificador" => "abst0050" "titulo" => "Diseño" ] 2 => array:2 [ "identificador" => "abst0055" "titulo" => "Contexto" ] 3 => array:2 [ "identificador" => "abst0060" "titulo" => "Pacientes" ] 4 => array:2 [ "identificador" => "abst0065" "titulo" => "Intervenciones" ] 5 => array:2 [ "identificador" => "abst0070" "titulo" => "Variables" ] 6 => array:2 [ "identificador" => "abst0075" "titulo" => "Resultados" ] 7 => array:2 [ "identificador" => "abst0080" "titulo" => "Conclusiones" ] ] ] ] "apendice" => array:1 [ 0 => array:1 [ "seccion" => array:1 [ 0 => array:4 [ "apendice" => "<p id="par0205" class="elsevierStylePara elsevierViewall">The following are the supplementary data to this article:<elsevierMultimedia ident="upi0005"></elsevierMultimedia><elsevierMultimedia ident="upi0010"></elsevierMultimedia><elsevierMultimedia ident="upi0015"></elsevierMultimedia></p>" "etiqueta" => "Appendix A" "titulo" => "Supplementary data" "identificador" => "sec0095" ] ] ] ] "multimedia" => array:9 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2113 "Ancho" => 2508 "Tamanyo" => 152898 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0085" class="elsevierStyleSimplePara elsevierViewall">Flow diagram of participants (dates of inclusion: between January 2018 and December 2020). ARDS<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>acute respiratory distress syndrome; ICU<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>intensive care unit; IMV<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>invasive mechanical ventilation.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1423 "Ancho" => 3341 "Tamanyo" => 315451 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0090" class="elsevierStyleSimplePara elsevierViewall">Agreement in classification of ARDS severity using PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio and P/FP<span class="elsevierStyleInf">E</span> index on day 1 (A) and day 3 (B). Blue boxes represent patients whose categories remained unchanged. Red boxes represent patients who were reclassified to a more severe category. Green boxes represent patients who were reclassified to a milder category. P/F<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio; P/FP<span class="elsevierStyleInf">E</span> index<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>PaO<span class="elsevierStyleInf">2</span>/(FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>PEEP).</p>" ] ] 2 => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 2750 "Ancho" => 3341 "Tamanyo" => 416872 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0095" class="elsevierStyleSimplePara elsevierViewall">Relationship between PEEP level and ARDS severity according to the PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span> ratio at day 1 (pictures A) and day 3 (picture C), and the P/FP<span class="elsevierStyleInf">E</span> index at day 1 (pictures B) and day 3 (picture D). ARDS<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>acute respiratory distress syndrome; PaO<span class="elsevierStyleInf">2</span>/FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>arterial partial pressure of oxygen to fraction of inspired oxygen ratio; PEEP<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>positive end-expiratory pressure; P/FP<span class="elsevierStyleInf">E</span> index<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>PaO<span class="elsevierStyleInf">2</span>/(FiO<span class="elsevierStyleInf">2</span><span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>PEEP).</p>" ] ] 3 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0105" class="elsevierStyleSimplePara elsevierViewall">Data are presented as the number (%) or the median (interquartile range). The <span class="elsevierStyleItalic">p</span>-values are calculated using the Mann–Whitney <span class="elsevierStyleItalic">U</span> test for continuous variables and chi-square test for categorical variables.</p><p id="spar0110" class="elsevierStyleSimplePara elsevierViewall">ARDS<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>acute respiratory distress syndrome; ICU<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>intensive care unit; MV<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>invasive mechanical ventilation; SAPS<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>Simplified Acute Physiology Score; SOFA<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>Sequential Organ Failure Assessment.</p>" "tablatextoimagen" => array:1 [ 0 => array:1 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Characteristics \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Total (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>217) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Survivors (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>87) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Nonsurvivors (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>130) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Age, years</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">63.0 (53.0–73.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">62.0 (51.5–72.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">64.5 (54.0–73.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.261 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Sex, male</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">103 (47.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">45 (51.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">58 (44.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.304 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Body mass index, kg/m</span><span class="elsevierStyleSup"><span class="elsevierStyleItalic">2</span></span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25.0 (24.1–27.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25.4 (24.3–27.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24.8 (23.5–27.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.444 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Chronic diseases</span><a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Chronic respiratory disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">35 (16.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 (11.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 (19.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.129 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Diabetes mellitus \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">48 (22.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16 (18.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">32 (24.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.279 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Immunoincompetence \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">64 (29.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21 (24.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">43 (3.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.157 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>High blood pressure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">128 (59.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">42 (48.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">86 (66.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.009 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Coronary artery disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">38 (17.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 (10.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 (22.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.023 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Other cardiovascular disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">33 (15.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 (9.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 (19.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.044 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Cancer \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">82 (37.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">30 (34.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">52 (40.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.411 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Chronic kidney disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">25 (11.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8 (9.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">17 (13.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.380 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Chronic liver disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">12 (5.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 (5.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 (5.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.000 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Length of stay before ICU admission, days</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6.0 (3.0–16.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7.0 (2.0–14.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6.0 (3.0–16.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.461 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Reason for ICU admission</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Acute respiratory failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">180 (82.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">77 (88.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">103 (79.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.075 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Shock \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">64 (29.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">23 (26.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">41 (31.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.419 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Rhythm disturbances \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">9 (4.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 (2.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 (5.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.264 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Acute abdomen \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 (9.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 (8.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">13 (10.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.626 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Severe acute pancreatitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 (2.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 (2.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 (2.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.997 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Disturbed consciousness \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">49 (22.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">20 (23.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 (22.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.906 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Intracranial mass effect \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24 (11.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">14 (16.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10 (7.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.053 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Liver failure \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7 (3.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 (1.1) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">6 (4.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.247 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">Type of patient</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.007 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Nonsurgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">134 (61.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">44 (50.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">90 (69.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Elective surgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">40 (18.4) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24 (27.6) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16 (12.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Emergency surgery \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">43 (19.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">19 (21.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">24 (18.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " colspan="5" align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">SAPS 3 score, points</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">55.0 (44.0–66.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">55.0 (42.5–65.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">55.0 (44.0–66.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.957 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">SOFA score, points</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8.0 (6.0–11.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4.0 (3.0–7.0) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8.0 (8.0–12.0)